CN100406045C - Capsule for treating dermatosis - Google Patents
Capsule for treating dermatosis Download PDFInfo
- Publication number
- CN100406045C CN100406045C CNB2005100102218A CN200510010221A CN100406045C CN 100406045 C CN100406045 C CN 100406045C CN B2005100102218 A CNB2005100102218 A CN B2005100102218A CN 200510010221 A CN200510010221 A CN 200510010221A CN 100406045 C CN100406045 C CN 100406045C
- Authority
- CN
- China
- Prior art keywords
- radix
- capsule
- effect
- rhizoma
- crude drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of capsule for treating psoriasis, eczema, pityriasis rosea, and seborrheic dermatitis is prepared from 12 Chinese-medicinal materials including rehmannia, oldenlandia, China root, red peony root, etc.
Description
(1) technical field
What the present invention relates to is a kind of medicine configuration product, specifically a kind of Chinese medicine for the treatment of skin class disease.
(2) background technology
The treatment difficulty of dermatosis such as psoriasis, acute and chronic eczema, pityriasis rosea, seborrheic dermatitis is big, very easily recurrence after controlling.Many at present employing hormones diseases are treated.
(3) summary of the invention
The object of the present invention is to provide a kind of dermopathic capsule of treatment that dermatosis is had the good curing effect.
The object of the present invention is achieved like this: the crude drug of every capsules is Radix Rehmanniae 30-40mg, favus skin 30-40mg, Hedyotidis Diffusae 30-40mg, Cornu Bubali 30-40mg, Rhizoma Smilacis Glabrae 30-40mg, Rhizoma Paridis 30-40mg, Radix Arnebiae (Radix Lithospermi) 15-20mg, Fructus Forsythiae 15-20mg, Radix Paeoniae Rubra 15-20mg, Cortex Moutan 8-12mg, Radix Sophorae Flavescentis 8-12mg and Radix Clematidis 8-12mg.
Through pulverizing, grinding to form fine powder, canned one-tenth capsule is product of the present invention with crude drug of the present invention.
Radix Rehmanniae bitter in the mouth in the product of the present invention has the effect of heat-clearing and toxic substances removing; Sweet, the little hardship of Hedyotidis Diffusae, cold has the effect of heat-clearing and toxic substances removing, relieving stranguria by diuresis, promoting blood circulation and stopping pain; Cornu Bubali bitter in the mouth, cold in nature has the effect of heat-clearing and toxic substances removing, removing heat from blood, is usually used in pestilence hyperpyrexia, macule etc.; The Fructus Forsythiae bitter in the mouth that is slightly cold has the effect of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, is usually used in carbuncle, acute mastitis, anemopyretic cold, excessive thirst coma, sends out diseases such as speckle; Cortex Moutan has and rushes down volt fire, dissipating blood stasis blood, the effect of heat clearing away and restlessness relieving; Rhizoma Smilacis Glabrae is sweet light, has the effect of removing damp-heat, easing joint movement; The favus skin bitter in the mouth, be slightly cold, have the effect of disappear pain, heat clearing away; Rhizoma Paridis has heat radiation, heat clearing away, detoxifcation, eliminating stagnation, repercussive effect; Radix Arnebiae (Radix Lithospermi) has the effect of detoxifcation, cathartic, damp eliminating; The Radix Paeoniae Rubra hardship, be slightly cold, have spasmolytic, antiinflammatory, analgesic effect, be usually used in controlling the carbuncle skin infection; Radix Clematidis has wind-damp dispelling, analgesic effect, is usually used in treating urticaria; Radix Sophorae Flavescentis has heat clearing away, antiinflammatory, digestion promoting function, is usually used in treating itching skin disease.The present invention cooperates these medicines, makes effective ingredient such as containing kurarinone, paeonol, β-ecdyson, daucosterol in the product.Each effective ingredient cooperatively interacts, and can receive good alleviation blood poison Sheng, sterilization detoxifcation, effects such as promoting blood circulation and cooling blood.Product of the present invention is used for the treatment of dermatosis such as psoriasis, acute and chronic eczema, pityriasis rosea, seborrheic dermatitis good effect.Treatment at 200 routine psoriatics is observed, and 10 days to 1 month, effective percentage reached 91%.200 routine pityriasis rosea patient treatments are observed, and effective percentage reached 99% in 10 days.300 routine acute and chronic eczema patient treatments were observed 10 days to 1 month, and effective percentage reaches 95%.
(4) specific embodiment
For example the present invention is done in more detail below and describes:
Get raw material ready in the ratio that contains Radix Rehmanniae 30-40mg, favus skin 30-40mg, Hedyotidis Diffusae 30-40mg, Cornu Bubali 30-40mg, Rhizoma Smilacis Glabrae 30-40mg, Rhizoma Paridis 30-40mg, Radix Arnebiae (Radix Lithospermi) 15-20mg, Fructus Forsythiae 15-20mg, Radix Paeoniae Rubra 15-20mg, Cortex Moutan 8-12mg, Radix Sophorae Flavescentis 8-12mg and Radix Clematidis 8-12mg in every capsules.Fine powder, canned one-tenth capsule are pulverized, ground to form to crude drug.
Get raw material ready in the ratio that contains Radix Rehmanniae 35mg, favus skin 35mg, Hedyotidis Diffusae 35mg, Cornu Bubali 35mg, Rhizoma Smilacis Glabrae 35mg, Rhizoma Paridis 35mg, Radix Arnebiae (Radix Lithospermi) 20mg, Fructus Forsythiae 20mg, Radix Paeoniae Rubra 20mg, Cortex Moutan 10mg, Radix Sophorae Flavescentis 10mg and Radix Clematidis 10mg in every capsules.Fine powder, canned one-tenth capsule are pulverized, ground to form to crude drug.
Claims (2)
1. treat dermopathic capsule for one kind, it is characterized in that: the crude drug of every capsules is Radix Rehmanniae 30-40mg, favus skin 30-40mg, Hedyotidis Diffusae 30-40mg, Cornu Bubali 30-40mg, Rhizoma Smilacis Glabrae 30-40mg, Rhizoma Paridis 30-40mg, Radix Arnebiae (Radix Lithospermi) 15-20mg, Fructus Forsythiae 15-20mg, Radix Paeoniae Rubra 15-20mg, Cortex Moutan 8-12mg, Radix Sophorae Flavescentis 8-12mg and Radix Clematidis 8-12mg.
2. the dermopathic capsule of treatment according to claim 1 is characterized in that: the crude drug of every capsules is Radix Rehmanniae 35mg, favus skin 35mg, Hedyotidis Diffusae 35mg, Cornu Bubali 35mg, Rhizoma Smilacis Glabrae 35mg, Rhizoma Paridis 35mg, Radix Arnebiae (Radix Lithospermi) 20mg, Fructus Forsythiae 20mg, Radix Paeoniae Rubra 20mg, Cortex Moutan 10mg, Radix Sophorae Flavescentis 10mg and Radix Clematidis 10mg.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100102218A CN100406045C (en) | 2005-07-27 | 2005-07-27 | Capsule for treating dermatosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100102218A CN100406045C (en) | 2005-07-27 | 2005-07-27 | Capsule for treating dermatosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1903303A CN1903303A (en) | 2007-01-31 |
| CN100406045C true CN100406045C (en) | 2008-07-30 |
Family
ID=37672765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100102218A Expired - Fee Related CN100406045C (en) | 2005-07-27 | 2005-07-27 | Capsule for treating dermatosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100406045C (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101095810B (en) * | 2007-07-16 | 2011-08-03 | 陆利群 | Decoction medicine for treating seborrhoeic dermatitis and method for preparing the same |
| CN101301344B (en) * | 2008-06-03 | 2011-10-26 | 凌志贤 | Oral Chinese medicine for treating blood-heat drug induced dermatitis |
| CN101322775B (en) * | 2008-07-16 | 2011-03-23 | 潍坊东方国际银屑病研究院 | Chinese medicine for treating psoriasis |
| CN102078435B (en) * | 2010-12-25 | 2012-09-05 | 马建国 | Medicinal oil for treating pityriasis rosea and preparation method thereof |
| CN102846830B (en) * | 2012-10-08 | 2014-06-11 | 杨洪义 | Combination medicine used for treating urticaria, as well as preparation method and application thereof |
| CN103800538B (en) * | 2013-12-23 | 2015-12-30 | 广西玉林制药集团有限责任公司 | A kind of Chinese medicine composition for the treatment of acute eczema |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1189343A (en) * | 1997-01-28 | 1998-08-05 | 黄北原 | Powder for curing psoriasis |
-
2005
- 2005-07-27 CN CNB2005100102218A patent/CN100406045C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1189343A (en) * | 1997-01-28 | 1998-08-05 | 黄北原 | Powder for curing psoriasis |
Non-Patent Citations (4)
| Title |
|---|
| 中医皮肤病方药研究. 喻文球.江西中医学院，第13卷第3期. 2001 |
| 中医皮肤病方药研究. 喻文球.江西中医学院，第13卷第3期. 2001 * |
| 中医药治疗银屑病近况. 罗清等.时珍国医国药，第15卷第12期. 2004 |
| 中医药治疗银屑病近况. 罗清等.时珍国医国药，第15卷第12期. 2004 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1903303A (en) | 2007-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178895B (en) | Chinese medicine composition for treating orthopedic disorders and preparation method thereof | |
| CN100406045C (en) | Capsule for treating dermatosis | |
| CN112843207A (en) | Formula and preparation method of smearing type thermal moxibustion ointment | |
| CN101716273A (en) | Traditional Chinese medicine for treating dysmenorrhea | |
| CN101129636A (en) | Medicament for treating pars nasalis inflammation | |
| CN101129872A (en) | Powder of phellodendron amurense adlay erysipelas | |
| CN101623352A (en) | Medicine for treating acne and preparation method thereof | |
| CN104000893A (en) | Traditional Chinese medicine oral liquid for treating rhinitis | |
| CN101249184B (en) | Medicine for treating osteoproliferation as well as its preparation method | |
| CN102580142B (en) | Chinese medicinal liniment for postoperative healing of orthopaedic surgery and preparation method | |
| CN104644857A (en) | Traditional Chinese medicine formula for treating acnes | |
| CN101239140A (en) | Chinese medicine for treating psoriasis | |
| CN102078432A (en) | Medicament for treating skin itch | |
| CN110934926A (en) | Application of oil of Liaopo mountain hundred herb in preparing medicine for treating arthralgia | |
| CN1261130C (en) | Medicine for dispelling tinea | |
| CN100382833C (en) | Mastosis treating Chinese medicine | |
| CN102743661B (en) | A kind of antipsoriatics thing and preparation method thereof | |
| CN101979073A (en) | Medicament for soothing liver and regulating Qi | |
| CN101647909B (en) | Externally-applied medicine for treating fracture | |
| CN106729433B (en) | Traditional Chinese medicine compound for treating skin carbuncle and swelling and preparation thereof | |
| CN102038904A (en) | Chinese prescription for treating leucoderma | |
| CN1973880A (en) | Externally applied medicine for treating gouty arthritis and its prepn | |
| CN1557365A (en) | Medicine | |
| CN105902718A (en) | External liniment for treating herpes zoster | |
| CN1418668A (en) | Chinese patent drug for treating bone ache, and its prepn. method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080730 |